The MHRA has approved depemokimab as an add on treatment for severe asthma and chronic rhinosinusitis with nasal polyps.

FDA approval moves trastuzumab deruxtecan in combination with pertuzumab into frontline treatment of unresectable or ...

The use of inhaled corticosteroids during pregnancy may protect against reduced lung function in infants born to mothers with ...

Re-treatment with ligelizumab is effective and generally well tolerated in patients with chronic spontaneous urticaria who ...

Hospital-level care at home was gaining traction even before the COVID pandemic, and for good reason: A study published in ...

The fear of expectation and the unknown may often lead patients to refuse screenings or tests. It’s your job to try and help ...

Families of children with complex chronic diseases report positive hospital-to-home transitions, but many children do not ...

Injuries during menstrual bleeding are less frequent but lead to more days lost than injuries in non-bleeding phases, ...

A new study shows that in patients with intermediate nonneovascular age-related macular degeneration, levodopa treatment is ...

When a wasp swarm stings a woman dozens of times in a small Sardinian town, a second-year resident — with very little ...

Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves' orbitopathy, ...

Women undergoing assisted reproductive technologies show a slightly higher risk for CVD than those not undergoing these ...